Review

Journal of Industrial Microbiology and Biotechnology

, Volume 33, Issue 7, pp 627-634

First online:

Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds

  • Simon SilverAffiliated withDepartment of Microbiology and Immunology, University of Illinois Email author 
  • , Le T. PhungAffiliated withDepartment of Microbiology and Immunology, University of Illinois
  • , Gregg SilverAffiliated withArgentum Medical LLC

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Silver products have been used for thousands of years for their beneficial effects, often for hygiene and in more recent years as antimicrobials on wounds from burns, trauma, and diabetic ulcers. Silver sulfadiazine creams (Silvazine and Flamazine) are topical ointments that are marketed globally. In recent years, a range of wound dressings with slow-release Ag compounds have been introduced, including Acticoat, Actisorb Silver, Silverlon, and others. While these are generally accepted as useful for control of bacterial infections (and also against fungi and viruses), key issues remain, including importantly the relative efficacy of different silver products for wound and burn uses and the existence of microbes that are resistant to Ag+. These are beneficial products needing further study, although each has drawbacks. The genes (and proteins) involved in bacterial resistance to Ag have been defined and studied in recent years.

Keywords

Silver toxicity Medical uses of silver Industrial uses of silver Wound treatments Resistance mechanism